josh@biondvax.com

­

About Josh Phillipson

Joshua Phillipson serves as Business Development and Marketing manager for BiondVax.

BiondVax Reports Positive Phase 2b Clinical Trial Results for its Universal Flu Vaccine

July 20th, 2017|

2b ביונדווקס מדווחת על תוצאות חיוביות בניסוי קליני שלב

July 20th, 2017|

ביונדווקס חתמה על הסכם שכירות עבור הקמת מתקן ייצור מסחרי בגודל בינוני לייצור חיסון השפעת האוניברסלי

July 18th, 2017|

BiondVax Signs Lease Agreement for Mid-Size Commercial Facility to Manufacture Universal Flu Vaccine

July 18th, 2017|

BiondVax’s CEO Provides First Half 2017 General Corporate Update

June 28th, 2017|

[FiercePharma] BiondVax nabs €20M loan to advance universal flu vaccine

June 19th, 2017|

[Horizon] Closing in on a universal flu vaccine

June 19th, 2017|

[Times of Israel] BiondVax gets €20 million loan for universal flu vaccine

June 19th, 2017|

European Investment Bank (EIB) supports Late-Stage Development and Production of BiondVax’s Universal Flu Vaccine Candidate under Horizon 2020 Initiative

June 19th, 2017|

BiondVax Announces First Quarter 2017 Financial Results and Update

May 30th, 2017|